Recombinant Escherichia coli glucokinase (Glk) is a genetically engineered enzyme produced by cloning and expressing the glk gene in E. coli. This ATP-dependent enzyme catalyzes the phosphorylation of glucose to glucose-6-phosphate (G6P), a critical step in glycolysis and carbohydrate metabolism . Unlike glucose uptake via the phosphoenolpyruvate-dependent phosphotransferase system (PTS), Glk phosphorylates intracellular glucose derived from disaccharide hydrolysis (e.g., lactose, maltose) .
| Property | Value/Description | Source |
|---|---|---|
| Gene locus | b2388 (JW2385) | |
| Molecular weight | 37.1 kDa (including His-tag) | |
| Substrate specificity | Glucose (Km = 0.78 mM), ATP (Km = 3.76 mM) | |
| Optimal pH | 9.0 |
| Parameter | Value | Conditions | Source |
|---|---|---|---|
| (glucose) | 0.78 mM | 5 mM ATP, pH 9.0, 37°C | |
| (ATP) | 3.76 mM | 5 mM glucose, pH 9.0, 37°C | |
| 158 U/mg | pH 9.0, 37°C |
Glucose phosphorylation: Critical for metabolizing internal glucose from disaccharides (e.g., maltose, trehalose) when PTS is inactive .
Energy conservation: Overexpression in evolved E. coli strains enhances ATP yield by bypassing PTS-dependent glucose uptake .
Carbon catabolite repression: Glk expression is reduced by 50% during growth on glucose .
FruR regulation: A FruR-binding motif upstream of glk modulates transcription, with fruR mutations increasing glk expression .
Succinate production: Evolved E. coli strains use Glk with GalP permease to increase PEP availability, improving succinate yields .
Nitrogen-limited fermentation: Glk overexpression mitigates metabolic slowdown under nitrogen stress .
Expression system: Recombinant Glk is produced in E. coli with >95% purity via nickel-chelate chromatography .
Stability: Retains activity in 20 mM Tris-HCl (pH 8.0), 0.15 M NaCl, and 10% glycerol at -20°C .
| Step | Details | Source |
|---|---|---|
| Cloning | glk inserted into pQE30 vector (Sma I site) | |
| Expression host | E. coli DH5α or BL21 | |
| Induction | 1 mM IPTG | |
| Purification | Ni²⁺ affinity chromatography | |
| Purity verification | SDS-PAGE (>95%) |
Redundant function: Native PTS minimizes Glk’s role in glucose metabolism unless pts genes are deleted .
Overexpression toxicity: High Glk levels repress maltose transport via competition for intracellular glucose .
KEGG: ecm:EcSMS35_2540
Recombinant E. coli glucokinase (glk) is an ATP-dependent kinase that phosphorylates glucose to glucose-6-phosphate (G6P), bypassing the phosphotransferase system (PTS) used for glucose uptake in wild-type strains . While native glucokinase plays a minor role in E. coli metabolism due to PTS dominance, recombinant versions enable controlled studies of glucose metabolism, bypassing PTS limitations. This is critical for analyzing G6P production in glycolysis, catabolite repression, or engineered metabolic pathways.
Methodological Note: Recombinant glucokinase is expressed in E. coli with high purity (>95%) and is validated for SDS-PAGE, mass spectrometry (MS), and functional assays . Researchers often use it to:
Study glucose metabolism in glk-deficient mutants.
Assess enzyme kinetics (e.g., Km for glucose = 0.78 mM, Vmax = 158 U/mg) .
Examine catabolite repression mechanisms, as overexpression of glk represses maltose system expression .
The kinetic profile of glucokinase (Km = 0.78 mM for glucose, Km = 3.76 mM for ATP, Vmax = 158 U/mg) dictates substrate concentrations and reaction conditions .
| Parameter | Value | Experimental Implication |
|---|---|---|
| Km (glucose) | 0.78 mM | Use glucose concentrations ≥1 mM to saturate enzyme. |
| Vmax | 158 U/mg | Optimize reaction time based on protein quantity. |
| Substrate Specificity | Glucose only | Avoid cross-reactivity with fructose/galactose. |
Advanced Consideration: Kinetic studies should account for ATP depletion in reactions. Use ATP-regenerating systems (e.g., phosphoenolpyruvate/pyruvate kinase) to maintain steady-state conditions for accurate Vmax measurements.
Activity can be quantified via:
ATP-Dependent Phosphorylation Assays:
SDS-PAGE and Western Blotting:
Enzyme Kinetics:
| Method | Advantages | Limitations |
|---|---|---|
| NADH-Linked Assays | High sensitivity, real-time kinetics | Requires coupled enzymes. |
| HPLC/MS | Confirmatory product analysis | Low throughput, high cost. |
| SDS-PAGE | Rapid purity assessment | No activity data. |
Glucose represses glk expression by ~50% through mechanisms involving FruR, a transcriptional regulator . A FruR binding motif is located 123 bp upstream of the glk promoter, suggesting direct regulation . Overexpression of FruR+ weakly decreases glk expression, while fruR mutations increase it. This repression ensures metabolic efficiency: glucose-6-phosphate from the PTS system is prioritized over glucokinase activity.
Experimental Design Tip: To study glk regulation, use glk-lacZ fusions to monitor expression under varying carbon sources. Include controls with fruR mutants to isolate regulatory effects.
Adaptive evolution experiments reveal that enzyme recruitment depends on trade-offs between catalytic efficiency and substrate specificity . For example, N-acetylmannosamine kinase (NanK) was preferentially recruited over N-acetylglucosamine kinase (NagK) or N-acetylmannosamine kinase (NanK), despite NagK having higher catalytic efficiency (kcat/Km = 2,400 M⁻¹s⁻¹ vs. NanK: ~15 M⁻¹s⁻¹) . Key factors include:
Metabolic Flux: NanK mutations enhanced glucokinase activity but reduced its native N-acetylmannosamine kinase activity, causing a trade-off in fitness.
Transcriptional Amplification: Early mutations increased nanK transcription, amplifying NanK levels to compensate for low activity.
| Kinase | Catalytic Efficiency (kcat/Km) | Recruitment Status |
|---|---|---|
| NagK | 2,400 M⁻¹s⁻¹ | Not recruited |
| Mak | 200 M⁻¹s⁻¹ | Not recruited |
| NanK | ~15 M⁻¹s⁻¹ | Recruited |
| AlsK | 15 M⁻¹s⁻¹ | Not recruited |
To maximize expression and activity:
Strain Selection: Use E. coli strains lacking native glucokinase (e.g., glk knockout) to avoid competition.
Induction Conditions:
Grow at 30–37°C using T7-based expression systems (e.g., BL21(DE3)).
Optimize IPTG concentration (0.1–1 mM) to balance yield and solubility.
Purification:
Advanced Strategy: Co-express molecular chaperones (e.g., GroES-GroEL) to improve protein folding.
Active recombinant glucokinase (e.g., Abcam ab208303) retains full enzymatic function, enabling studies of glucose phosphorylation kinetics and metabolic engineering applications . Non-active versions (e.g., ab183231) may lack cofactor binding or catalytic residues but are suitable for structural studies (e.g., crystallization).
| Property | Active (ab208303) | Non-Active (ab183231) |
|---|---|---|
| ATP Binding | Yes | No/Partial |
| G6P Production | Yes | No |
| Suitable For | Kinetic assays | Structural studies |
| Handling Precautions | Biohazard containment | Standard |
In vitro, recombinant glucokinase exhibits high activity due to optimized conditions (e.g., excess ATP, absence of competing pathways) . In vivo, the PTS system dominates glucose uptake, rendering glucokinase redundant unless engineered for specific metabolic tasks.
Compare Activity in glk-Deficient Strains:
Measure G6P levels in strains expressing glucokinase vs. wild-type.
Monitor Metabolic Flux:
Use isotopic labeling (e.g., ¹³C-glucose) to track G6P production in engineered pathways.
Substrate Competition: Glucokinase competes with PTS for glucose, requiring precise regulation.
Catabolite Repression: Overexpression represses maltose system genes, complicating co-expression with other sugar utilization pathways .
Evolutionary Trade-offs: Recruiting alternative kinases (e.g., NanK) reduces fitness on native substrates .
Engineer strains with constitutive glk expression and pts-deficient mutations.
Use synthetic promoters to decouple glk expression from endogenous regulators.
Glucokinase activity impacts:
Glycolytic Flux: G6P feeds into glycolysis, bypassing PTS-regulated entry points.
Catabolite Repression: High G6P levels inhibit the maltose system via MalK-dependent mechanisms .
Redox Balance: ATP consumption in glucokinase reactions may alter NAD+/NADH ratios.
Experimental Design: Co-monitor G6P, ATP, and NADH levels to map metabolic interactions.